Scientific Publications
Manuscripts
Case studies for overcoming challenges in using big data in cancer
Cancer Research
Sweeney SM et al
Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database
JCO Oncology Practice
Ray et al
Retrospective analysis of real‐world management of EGFR‐mutated advanced NSCLC, after first‐line EGFR‐TKI treatment: US treatment patterns, attrition,…
Drugs Real World Outcomes
Nieva J et al
Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological maligna…
The Lancet Haematology
Thanarajasingam G et al.
Cancer registry data linkage of electronic health record data from ASCO’s CancerLinQ: Evaluation of advantages, limitations, and lessons learned
JCO Clinical Cancer Informatics
Charlton et al.
Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a Cance…
Breast Cancer Research and Treatment
Miller et al.
Quantitating and Assessing Interoperability Between Electronic Health Records
Journal of the American Medical Informatics Association
Bernstam et al.
The Chasm Between Cancer Quality Measures and EHR Data Quality
JCO Clinical Cancer Informatics
Schorer et al.
Abstracts
Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis
2022 ASH Annual Meeting
Cooper JD
Secondary primary malignancies in adolescent and young adults with multiple myeloma: An ASCO CancerLinQ analysis
2022 ASH Annual Meeting
Gibson SJ
Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021
2022 ASH Annual Meeting
Bhandari S
Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
2022 San Antonio Breast Cancer Symposium
Sukumar JS
Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutat…
2022 ESMO Congress
Altorki NK
Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data
2022 World Conference on Lung Cancer
Behera M et al
Comparison of DNA sequencing, immunohistochemistry, and in-situ hybridization techniques to determine HER2 status in metastatic breast cancer patients
ASCO 2022 Annual Meeting
Lal LS
Characterizing node-negative non-small cell lung cancer patients with similarity networks: A CancerLinQ Discovery analysis
ASCO 2022 Annual Meeting
Moen EL
Impact of trial site selection on minority patient recruitment in prostate cancer trials
ASCO 2022 Annual Meeting
Lagor C
